Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.
about
Metalloproteinase inhibitors: status and scope from marine organismsNS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon SystemStructural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTORCharacterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATIONHigh Resolution NMR-based Model for the Structure of a scFv-IL-1 Complex: POTENTIAL FOR NMR AS A KEY TOOL IN THERAPEUTIC ANTIBODY DESIGN AND DEVELOPMENTStructure-function relationship in an archaebacterial methionine sulphoxide reductase BStructural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicansStructure and Interactions of the Human Programmed Cell Death 1 ReceptorRibosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acidMycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma FactorsStructure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion releaseThe N-terminus of the human RecQL4 helicase is a homeodomain-like DNA interaction motifHigh resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3Structure and regulatory role of the C-terminal winged helix domain of the archaeal minichromosome maintenance complexAutomated evaluation of chemical shift perturbation spectra: New approaches to quantitative analysis of receptor-ligand interaction NMR spectraHow matrix metalloproteinases regulate cell behaviorConformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formationMetal binding to the N-terminal cytoplasmic domain of the PIB ATPase HMA4 is required for metal transport in Arabidopsis.Discovery and binding studies on a series of novel Pin1 ligands.Role of steric effects in protein-directed enediyne cycloaromatization of neocarzinostatin.Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand bindingHigh-resolution NMR studies of structure and dynamics of human ERp27 indicate extensive interdomain flexibilityInteraction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.The solution structure of REF2-I reveals interdomain interactions and regions involved in binding mRNA export factors and RNA.Effects of membrane mimetics on cytochrome P450-cytochrome b5 interactions characterized by NMR spectroscopy.Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations.15N-1H scalar coupling perturbation: an additional probe for measuring structural changes due to ligand binding.P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications.Chemical shift mapping of RNA interactions with the polypyrimidine tract binding protein.Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97.On the interaction of Helicobacter pylori NikR, a Ni(II)-responsive transcription factor, with the urease operator: in solution and in silico studies.Comprehensive structural analysis of designed incomplete polypeptide chains of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus.Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome b 5 and Cytochrome c.Protein disulfide-isomerase interacts with a substrate protein at all stages along its folding pathway.Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIESStructural insights into interaction between mammalian methionine sulfoxide reductase B1 and thioredoxin.Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.
P2860
Q21296828-6961820D-1C3D-49BD-BAC3-0F06D2AD8E50Q27485332-F0B8157B-46FC-4684-8B8C-7F5F2A881DB3Q27647018-B902501D-9487-46D4-8BC6-D2A3F48FB991Q27653715-488FE140-1141-4C40-80E1-AD17967FE6ABQ27657542-870778AE-A470-4EFD-8A59-936B0C068BEDQ27666490-CA22C272-C09C-42CA-AA72-5F512B089EECQ27673272-DD4EAFE7-2CA4-4670-B9BD-526CB60E21E7Q27676419-3561C917-8BBC-4B6C-AD2B-FAAD5F3E852EQ27677114-5E80905F-2316-47A3-A12C-140127A25999Q27677177-484D95B5-B023-46DF-8907-2F77CEFF546EQ27679913-BBF04827-CBA9-4CAF-AF04-65AFF3F3C1BFQ27681367-C4D2E56E-74EB-481D-BFDD-CC73BB7AFB66Q27765120-15FEF11C-EDB7-44B1-BC09-84669E09C72BQ28652461-DC5B3E36-4D63-4DD0-A98A-6EF719AC7F5AQ28828615-C6AD1F90-650A-431B-8023-EF07E6316281Q29620360-F132F9B0-31E2-448B-AB24-A0BFEE5B1733Q30357995-93941784-ED3D-4FA7-B94E-7476A1A53C5EQ30383754-42C02931-1D29-4EA6-9F23-17E9C1CE66CCQ30859183-17263DCB-F3CB-4BD7-B202-5AA15587BBC0Q33350520-29170BAC-0859-490B-95E7-634DD1F23FA7Q34145063-6CB5BF43-4D7E-46B6-9B35-CCB6717B1CC8Q34371893-B6DF0862-8EC9-48BB-A612-27D4E4805F8CQ34541386-5C72313A-70D5-4AD8-8F73-609D9E8E7D26Q35110861-53F24ED4-432C-4093-8603-5EB3D485A6B8Q35608108-64D67A07-E97F-431B-96E4-73F6A61265BFQ35884654-528B7E56-179B-4790-A910-D6231BAC835AQ36443324-2CDB3AC9-0FCA-4800-923B-9EEE8899F049Q36580674-00DD2CDA-A198-48CE-BE7A-4C78EA05DDBEQ36987704-630FA016-6EFD-4458-95F2-B8BDBD407BA7Q37000242-C7D4F95C-D6EC-427F-AB8C-264220283BF7Q38293020-381F470B-5957-48E2-8488-086D170F69BDQ40775969-EF7F1405-2A4D-4B6E-B7DB-62C550A21058Q41092715-4A1E7A4A-EA6E-4083-A58F-D1BC2EE2C023Q41153580-D9109D82-D947-471D-AB1F-BAE5AB84892FQ41353184-8BD899C6-6BE3-47DE-8E72-7380651D8A76Q41880177-BC37B249-1290-4A31-A2C6-0CF3A65C1331Q42380103-04D6DF94-0D0F-4DC2-BBD5-6F266357DDCBQ42566781-82E2978C-C409-41DA-A19A-9167242AC0A7Q42653828-412817C6-ABCD-4145-8241-84760654E1D0Q43069439-FCD22774-7F76-4FA2-9EE3-7B2DC106E054
P2860
Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Mapping the binding site for m ...... R chemical shift perturbation.
@ast
Mapping the binding site for m ...... R chemical shift perturbation.
@en
type
label
Mapping the binding site for m ...... R chemical shift perturbation.
@ast
Mapping the binding site for m ...... R chemical shift perturbation.
@en
prefLabel
Mapping the binding site for m ...... R chemical shift perturbation.
@ast
Mapping the binding site for m ...... R chemical shift perturbation.
@en
P2093
P356
P1433
P1476
Mapping the binding site for m ...... R chemical shift perturbation.
@en
P2093
Freedman RB
Frenkiel TA
Williamson RA
P304
13882-13889
P356
10.1021/BI9712091
P407
P577
1997-11-01T00:00:00Z